Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Hypertension management in chronic kidney disease: translating guidelines into daily practice.

De Nicola L, Borrelli S, Chiodini P, Zamboli P, Iodice C, Gabbai FB, Conte G, Minutolo R.

J Nephrol. 2011 Nov-Dec;24(6):733-41. doi: 10.5301/JN.2011.6335.

PMID:
21319133
2.

Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study.

Wang LY, Yin DX, Zhang DL, Xu R, Cui WY, Liu WH.

Int Urol Nephrol. 2013 Oct;45(5):1345-53. doi: 10.1007/s11255-012-0332-8. Epub 2012 Dec 7.

PMID:
23225078
3.

Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.

Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, Rodríguez-Artalejo F, Tamargo J; CLUE Study Group Investigators.

Hypertension. 2004 Jun;43(6):1338-44. Epub 2004 Apr 26.

4.

One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.

Tomino Y, Shimizu Y, Hamada C, Kurusu A, Ohsawa I, Suzuki Y, Tsuge T, Io H, Kobayashi N, Takeda Y, Asanuma K, Tanaka Y, Suzuki H, Nakata J, Takara K, Horikoshi S.

J Nephrol. 2011 Nov-Dec;24(6):756-63. doi: 10.5301/JN.2011.6383.

PMID:
21360472
5.

Management of hypertension in chronic kidney disease: the Italian multicentric study.

De Nicola L, Minutolo R, Gallo C, Zoccali C, Cianciaruso B, Conte M, Lupo A, Fuiano G, Gallucci M, Bonomini M, Chiodini P, Signoriello G, Bellizzi V, Mallamaci F, Nappi F, Conte G.

J Nephrol. 2005 Jul-Aug;18(4):397-404.

PMID:
16245243
6.

Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfè G, Boschi G, Brancati C, Iaccarino P, Conte G.

Am J Kidney Dis. 2005 Jul;46(1):18-25.

PMID:
15983953
7.

Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.

Ellis D, Moritz ML, Vats A, Janosky JE.

Am J Hypertens. 2004 Oct;17(10):928-35.

PMID:
15485756
8.

Blood pressure control and comorbidity in a nephrology clinic.

Triolo L, Cattaruzza MS, Sicoli R, Ansali F, Malaguti M, Osborn J, Biagini M.

J Nephrol. 2004 Nov-Dec;17(6):808-12.

PMID:
15593055
9.

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL.

Ann Intern Med. 1995 Nov 15;123(10):754-62.

PMID:
7574193
10.

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.

Othman M, Kawar B, El Nahas AM.

Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.

PMID:
19590231
11.

Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease.

De Nicola L, Borrelli S, Gabbai FB, Chiodini P, Zamboli P, Iodice C, Vitiello S, Conte G, Minutolo R.

Kidney Blood Press Res. 2011;34(1):58-67. doi: 10.1159/000322923. Epub 2011 Jan 4.

PMID:
21212686
12.

Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.

Takenaka T, Uchida K, Kojima E, Gen S, Nodaira Y, Hoshi H, Kato N, Takane H, Ohno Y, Suzuki H.

Clin Exp Hypertens. 2011;33(4):210-5. doi: 10.3109/10641963.2011.583965.

PMID:
21699446
13.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

14.

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.

PMID:
10845831
16.

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.

Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C.

Hypertension. 1997 Feb;29(2):641-50.

17.

Correlates of systolic hypertension in patients with chronic kidney disease.

Agarwal R, Andersen MJ.

Hypertension. 2005 Sep;46(3):514-20. Epub 2005 Aug 15.

18.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
19.

Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.

Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.

Am J Kidney Dis. 2006 Jan;47(1):78-87.

PMID:
16377388
20.

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.

Am J Kidney Dis. 2007 Dec;50(6):908-17.

PMID:
18037091
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk